{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T16:07:55Z","timestamp":1789834075759,"version":"4.0.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T00:00:00Z","timestamp":1567728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T00:00:00Z","timestamp":1567728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s00535-019-01619-0","type":"journal-article","created":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T17:29:03Z","timestamp":1567790943000},"page":"205-216","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Impact of sustained virological response with DAAs on gastroesophageal varices and Baveno criteria in HCV\u2013cirrhotic patients"],"prefix":"10.1007","volume":"55","author":[{"given":"Marc","family":"Puigveh\u00ed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda-Carlota","family":"Londo\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Torras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Lorente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Vergara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Maria","family":"Morillas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Masnou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trinidad","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireia","family":"Miquel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolfo","family":"Gallego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabela","family":"Lens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7191-6081","authenticated-orcid":false,"given":"Jose Antonio","family":"Carri\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,6]]},"reference":[{"key":"1619_CR1","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1053\/j.gastro.2008.03.007","volume":"134","author":"AJ Sanyal","year":"2008","unstructured":"Sanyal AJ, Bosch J, Blei A, et al. Portal hypertension and its complications. Gastroenterology. 2008;134:1715\u201328.","journal-title":"Gastroenterology"},{"key":"1619_CR2","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.gastrohep.2012.02.009","volume":"35","author":"J Bosch","year":"2012","unstructured":"Bosch J, Abraldes JG, Albillos A, et al. Portal hypertension: recommendations for evaluation and treatment: consensus document sponsored by the Spanish Association for the Study of the Liver (AEEH) and the Biomedical Research Network Center for Liver and Digestive Diseases (CIBERehd). Gastroenterol Hepatol. 2012;35:421\u201350.","journal-title":"Gastroenterol Hepatol"},{"key":"1619_CR3","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","volume":"44","author":"G D'Amico","year":"2006","unstructured":"D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44:217\u201331.","journal-title":"J Hepatol"},{"key":"1619_CR4","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/ajg.2009.31","volume":"104","author":"S Bruno","year":"2009","unstructured":"Bruno S, Zuin M, Crosignani A, et al. Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study. Am J Gastroenterol. 2009;104:1147\u201358.","journal-title":"Am J Gastroenterol"},{"key":"1619_CR5","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1002\/hep.21907","volume":"46","author":"G Garcia-Tsao","year":"2007","unstructured":"Garcia-Tsao G, Sanyal AJ, Grace ND, et al. Practice Guidelines Committee of the American Association for the study of liver D, Practice Parameters Committee of the American College of G. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007;46:922\u201338.","journal-title":"Hepatology"},{"key":"1619_CR6","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","volume":"63","author":"R de Franchis","year":"2015","unstructured":"de Franchis R, Baveno VIF. Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63:743\u201352.","journal-title":"J Hepatol"},{"key":"1619_CR7","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/j.ultrasmedbio.2003.07.001","volume":"29","author":"L Sandrin","year":"2003","unstructured":"Sandrin L, Fourquet B, Hasquenoph JM, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003;29:1705\u201313.","journal-title":"Ultrasound Med Biol"},{"key":"1619_CR8","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.jhep.2011.01.051","volume":"55","author":"MA Robic","year":"2011","unstructured":"Robic MA, Procopet B, Metivier S, et al. Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study. J Hepatol. 2011;55:1017\u201324.","journal-title":"J Hepatol"},{"key":"1619_CR9","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.jhep.2011.07.005","volume":"56","author":"L Castera","year":"2012","unstructured":"Castera L, Pinzani M, Bosch J. Non invasive evaluation of portal hypertension using transient elastography. J Hepatol. 2012;56:696\u2013703.","journal-title":"J Hepatol"},{"key":"1619_CR10","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.jhep.2016.06.021","volume":"65","author":"JB Maurice","year":"2016","unstructured":"Maurice JB, Brodkin E, Arnold F, et al. Validation of the Baveno VI criteria to identify low risk cirrhotic patients not requiring endoscopic surveillance for varices. J Hepatol. 2016;65:899\u2013905.","journal-title":"J Hepatol"},{"key":"1619_CR11","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1002\/hep.29363","volume":"66","author":"S Augustin","year":"2017","unstructured":"Augustin S, Pons M, Maurice JB, et al. Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease. Hepatology. 2017;66:1980\u20138.","journal-title":"Hepatology"},{"key":"1619_CR12","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1002\/hep.21665","volume":"45","author":"F Vizzutti","year":"2007","unstructured":"Vizzutti F, Arena U, Romanelli RG, et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology. 2007;45:1290\u20137.","journal-title":"Hepatology"},{"key":"1619_CR13","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1053\/j.gastro.2017.07.016","volume":"153","author":"S Lens","year":"2017","unstructured":"Lens S, Alvarado-Tapias E, Marino Z, et al. Effects of all-oral anti-viral therapy on HVPG and systemic hemodynamics in patients with hepatitis C virus-associated cirrhosis. Gastroenterology. 2017;153:1273\u201383.","journal-title":"Gastroenterology"},{"key":"1619_CR14","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1111\/jvh.12578","volume":"23","author":"V Knop","year":"2016","unstructured":"Knop V, Hoppe D, Welzel T, et al. Regression of fibrosis and portal hypertension in HCV-associated cirrhosis and sustained virologic response after interferon-free antiviral therapy. J Viral Hepat. 2016;23:994\u20131002.","journal-title":"J Viral Hepat"},{"key":"1619_CR15","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1001\/jama.2012.144878","volume":"308","author":"AJ van der Meer","year":"2012","unstructured":"van der Meer AJ, Veldt BJ, Feld JJ, et al. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. JAMA. 2012;308:2584\u201393.","journal-title":"JAMA"},{"key":"1619_CR16","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1056\/NEJMoa044456","volume":"353","author":"RJ Groszmann","year":"2005","unstructured":"Groszmann RJ, Garcia-Tsao G, Bosch J, et al. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med. 2005;353:2254\u201361.","journal-title":"N Engl J Med"},{"key":"1619_CR17","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1053\/j.gastro.2016.03.036","volume":"151","author":"V Di Marco","year":"2016","unstructured":"Di Marco V, Calvaruso V, Ferraro D, et al. Effects of eradicating hepatitis C virus infection in patients with cirrhosis differ with stage of portal hypertension. Gastroenterology. 2016;151:130\u20139.","journal-title":"Gastroenterology"},{"key":"1619_CR18","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.jhep.2016.05.027","volume":"65","author":"M Mandorfer","year":"2016","unstructured":"Mandorfer M, Kozbial K, Schwabl P, et al. Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension. J Hepatol. 2016;65:692\u20139.","journal-title":"J Hepatol"},{"key":"1619_CR19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/hep.20506","volume":"41","author":"M Ziol","year":"2005","unstructured":"Ziol M, Handra-Luca A, Kettaneh A, et al. Non-invasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology. 2005;41:48\u2013544.","journal-title":"Hepatology"},{"key":"1619_CR20","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1155\/2011\/954812","volume":"31","author":"A Berzigotti","year":"2011","unstructured":"Berzigotti A, Ashkenazi E, Reverter E, et al. Non-invasive diagnostic and prognostic evaluation of liver cirrhosis and portal hypertension. Dis Markers. 2011;31:129\u201338.","journal-title":"Dis Markers"},{"key":"1619_CR21","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/jvh.12296","volume":"22","author":"JA Carrion","year":"2015","unstructured":"Carrion JA, Puigvehi M, Coll S, et al. Applicability and accuracy improvement of transient elastography using the M and XL probes by experienced operators. J Viral Hepat. 2015;22:297\u2013306.","journal-title":"J Viral Hepat"},{"key":"1619_CR22","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1111\/jgh.13762","volume":"32","author":"M Puigvehi","year":"2017","unstructured":"Puigvehi M, Broquetas T, Coll S, et al. Impact of anthropometric features on the applicability and accuracy of FibroScan((R)) (M and XL) in overweight\/obese patients. J Gastroenterol Hepatol. 2017;32:1746\u201353.","journal-title":"J Gastroenterol Hepatol"},{"key":"1619_CR23","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jhep.2015.03.025","volume":"63","author":"European Association for Study of L","year":"2015","unstructured":"European Association for Study of L. EASL recommendations on treatment of hepatitis C 2015. J Hepatol. 2015;63:199\u2013236.","journal-title":"J Hepatol"},{"key":"1619_CR24","unstructured":"WHO toxicity grading scale for determining the severity of adverse events. Section VIII: appendices. Monitoring and reporting adverse events, pp\u00a062\u2013157. https:\/\/www.docdatabase.net\/more-who-toxicity-grading-scale-for-determining-the-severity-of-adverse--609754.html. Accessed 6 Feb 2003."},{"key":"1619_CR25","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","volume":"56","author":"European Association For The Study Of The L, European Organisation For R, Treatment Of C","year":"2012","unstructured":"European Association For The Study Of The L, European Organisation For R, Treatment Of C. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56:908\u201343.","journal-title":"J Hepatol"},{"key":"1619_CR26","first-page":"e13","volume":"24","author":"SM Grundy","year":"2004","unstructured":"Grundy SM, Brewer HB Jr, Cleeman JI, et al. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute\/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol. 2004;24:e13\u2013e1818.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1619_CR27","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00508-012-0190-5","volume":"124","author":"T Reiberger","year":"2012","unstructured":"Reiberger T, Ferlitsch A, Payer BA, et al. Noninvasive screening for liver fibrosis and portal hypertension by transient elastography-a large single center experience. Wien Klin Wochenschr. 2012;124:395\u2013402.","journal-title":"Wien Klin Wochenschr"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-019-01619-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00535-019-01619-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-019-01619-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T00:53:59Z","timestamp":1659056039000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00535-019-01619-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,6]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["1619"],"URL":"https:\/\/doi.org\/10.1007\/s00535-019-01619-0","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,6]]},"assertion":[{"value":"23 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"MCL: advisory fees from Janssen, MSD, AbbVie, Gilead and BMS. XT: Speaker fees from AbbVie, MSD and Gilead; advisory board for Gilead and MSD. SL: lecture fees from Gilead, AbbVie, Merck, BMS and Janssen. MV: lecture fees from Gilead Sciences, AbbVie and MSD. RMM: Speaker fees from Gilead, AbbVie, Merck, BMS, Janssen and Intercept. TS: Speaker fees from Gilead, AbbVie, and MSD. MM: lecture fees from Gilead, AbbVie and Merck. SL: speaker and consultant fees from Gilead, AbbVie and Janssen. JAC: lecture fees from Bristol Myers Squibb, Gilead Sciences, Roche\/Genentech and Jansen; the remaining authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}